Location History:
- New Yok, NY (US) (1998)
- New York, NY (US) (1988 - 2012)
Company Filing History:
Years Active: 1988-2012
Title: Emil Claus Gotschlich: Innovator in Glycosyltransferases
Introduction
Emil Claus Gotschlich is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the area of glycosyltransferases. With a total of 10 patents to his name, Gotschlich's work has advanced the understanding and application of oligosaccharide synthesis.
Latest Patents
One of Gotschlich's latest patents focuses on glycosyltransferases for the biosynthesis of oligosaccharides, along with the genes encoding them. This invention is directed towards nucleic acids that encode glycosyltransferases and the proteins they produce. The patent outlines methods for synthesizing oligosaccharides using these glycosyltransferases. Notably, it identifies a glycosyltransferase locus containing five open reading frames for five different glycosyltransferases. The functionally active glycosyltransferases are characterized by their ability to catalyze specific reactions, such as adding Gal β1→4 to GlcNAc or Glc, and adding GalNAc or GlcNAc β1→3 to Gal. These glycosyltransferases are particularly suited for synthesizing oligosaccharides that mimic important biological structures.
Career Highlights
Gotschlich is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the field of glycosylation and its applications in medicine and biotechnology. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
Some of Gotschlich's notable coworkers include Milan S Blake and Gregory J Russell-Jones. Their collaborative efforts have contributed to the success of various research projects and patents.
Conclusion
Emil Claus Gotschlich's contributions to the field of glycosyltransferases have paved the way for advancements in oligosaccharide synthesis. His innovative work continues to impact the scientific community and holds promise for future applications in biotechnology and medicine.